Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Urinary Tract Infection IV: Nursing Management

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Under-reporting of carcinoma in situ in patients with high-grade papillary non-muscle-invasive bladder cancer.

Bladder cancer (Amsterdam, Netherlands)·2026

Same author

Microscopic Spermatic Cord Denervation for Chronic Scrotal Content Pain Following Inguinal Hernia Repair: Outcomes and Predictors of Success.

Urology·2025

Same author

Urinalysis is predictive for absence of urinary tract infection in men with and without catheters.

Neurourology and urodynamics·2024

Same author

Sacral neuromodulation device biofilm differs in the absence and presence of infection, harbors antibiotic resistance genes, and is reproducible in vitro.

Neurourology and urodynamics·2024

Same author

Reply by Authors.

The Journal of urology·2024

Same author

A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial.

The Journal of urology·2024

Search research articles

Related Experiment Videos

Pharmacotherapy of prostatitis.

Devon C Snow¹, Daniel A Shoskes

¹Glickman Urological and Kidney Institute, Cleveland Clinic, Desk Q10-1, 9500 Euclid Ave, Cleveland, OH 44195, USA.

Expert Opinion on Pharmacotherapy

|June 24, 2010

Summary

This summary is machine-generated.

Prostatitis encompasses diverse syndromes, with chronic prostatitis/chronic pelvic pain syndrome being particularly challenging. A multimodal approach, guided by the UPOINT technique, is essential for effective patient treatment.

Related Experiment Videos

Area of Science:

Urology
Andrology
Men's Health

Background:

Prostatitis is a common and debilitating condition affecting quality of life.
Four distinct syndromes exist, each with unique causes, treatments, and outcomes.
Bacterial prostatitis requires targeted antibiotic therapy, while chronic prostatitis/chronic pelvic pain syndrome presents significant treatment challenges.

Purpose of the Study:

To review current diagnostic and therapeutic strategies for prostatitis syndromes.
To explore emerging treatments for prostatitis.
To provide a framework for understanding and managing the spectrum of prostatitis.

Main Methods:

Review of current literature on prostatitis categories and therapies.
Discussion of established and novel treatment approaches.
Introduction of the UPOINT technique for patient phenotyping.

Main Results:

Understanding the current diagnostic and management framework for prostatitis is crucial.
The UPOINT technique aids in classifying patients with chronic prostatitis/chronic pelvic pain syndrome.
Multimodal therapy selection is driven by clinical phenotyping.

Conclusions:

Prostatitis is a heterogeneous condition with varied presentations.
Chronic prostatitis/chronic pelvic pain syndrome is multifactorial, necessitating a comprehensive treatment strategy.
The UPOINT technique facilitates personalized, multimodal treatment for chronic prostatitis/chronic pelvic pain syndrome.